Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Teva And AbCellera Enter Into Agreement To Discover Rare Monoclonal Antibodies

 

Teva And AbCellera Enter Into Agreement To Discover Rare Monoclonal Antibodies

2016-02-26 02:15:58| drugdiscoveryonline News Articles

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) and AbCellera have entered into a collaborative research agreement whereby AbCellera will apply its high-throughput single cell antibody platform for the discovery of rare monoclonal antibodies.

Tags: enter agreement discover rare

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.11 Tropical Storm Rafael Graphics 05.11 Tropical Storm Rafael Wind Speed Probabilities Number 7 05.11 Tropical Storm Rafael Public Advisory Number 7 05.11 Summary for Tropical Storm Rafael (AT3/AL182024) 05.11 Tropical Storm Rafael Forecast Advisory Number 7 05.11 Boeing strike ends as workers back 38% pay rise deal 05.11 Tropical Storm Rafael Public Advisory Number 6A 05.11 Summary for Tropical Storm Rafael (AT3/AL182024) More »